ROVAMYCINE 3MUI tablets medication leaflet

J01FA02 spiramycin • Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins

Spiramycin is a macrolide antibiotic used to treat infections caused by susceptible bacteria. It is effective against respiratory infections, skin and soft tissue infections, but is particularly used for the prevention and treatment of toxoplasmosis in pregnant women to reduce the risk of transmission to the fetus.

It is administered orally, usually in tablet form, or intravenously, depending on the severity of the infection. The dosage and duration of treatment are determined by the doctor based on the type and severity of the infection.

Common side effects include nausea, vomiting, diarrhea, abdominal pain, and allergic reactions such as skin rashes. In rare cases, it may cause more severe reactions, such as hepatotoxicity or severe allergic responses.

Spiramycin is contraindicated in individuals with hypersensitivity to macrolides. It is important for patients to strictly follow their doctor's instructions and not discontinue treatment prematurely to prevent the development of bacterial resistance.

ROVAMYCINE 3MUI tablets SANOFI, spiramycin

General data about ROVAMYCINE 3MUI

Substance: spiramycin

Date of last drug list: 01-06-2025

Commercial code: W63534002

Concentration: 3MUI

Pharmaceutical form: tablets

Quantity: 10

Product type: original

Price: 31.72 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FAMAR LYON - FRANTA

Holder: SANOFI ROMANIA S.R.L. - ROMANIA

Number: 5741/2013/02

Shelf life: 3 years

Concentrations available for spiramycin

1.5MUI, 3MUI

Compensation lists for ROVAMYCINE 3MUI SANOFI

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

31.72 RON

9.48 RON

22.24 RON

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

31.72 RON

31.72 RON

0.00 RON